Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
- PublisherSPRINGER
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1976
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Months | % Papers published |
---|---|
0-3 | 35% |
4-6 | 48% |
7-9 | 13% |
>9 | 4% |
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Cancer Immunology, Immunotherapy been publishing? 
The Cancer Immunology, Immunotherapy has been publishing since 1976 till date.
How frequently is the Cancer Immunology, Immunotherapy published? 
Cancer Immunology, Immunotherapy is published Monthly.
Who is the publisher of Cancer Immunology, Immunotherapy? 
The publisher of Cancer Immunology, Immunotherapy is SPRINGER.
How can I view the journal metrics of Cancer Immunology, Immunotherapy on editage? 
For the Cancer Immunology, Immunotherapy metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Cancer Immunology, Immunotherapy? 
The eISSN number is 1432-0851 and pISSN number is 0340-7004 for Cancer Immunology, Immunotherapy.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.